We are live on
!
Find out more
TCM
Tanaka Capital Management Portfolio holdings
AUM
$59.9M
This Fund
S&P 500
This Quarter
Est. Return
-2.43%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$44.4M
AUM Growth
-$2.01M
(-4.3%)
Cap. Flow
-$604K
Cap. Flow
% of AUM
-1.36%
Top 10 Holdings %
Top 10 Hldgs %
61.89%
Holding
93
New
3
Increased
8
Reduced
23
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LGF
Lions Gate Entertainment
LGF
|
+$1.85M |
| 2 |
Tesla
TSLA
|
+$1.76M |
| 3 |
PARAA
Paramount Global Class A
PARAA
|
+$1.26M |
| 4 |
CPRX
Catalyst Pharmaceutical
CPRX
|
+$884K |
| 5 |
ProShares UltraPro Short S&P 500
SPXU
|
+$775K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$2.12M |
| 2 |
Nu Skin
NUS
|
+$1.85M |
| 3 |
Synaptics
SYNA
|
+$850K |
| 4 |
CELG
Celgene Corp
CELG
|
+$713K |
| 5 |
OSI Systems
OSIS
|
+$573K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.77% |
| 2 | Healthcare | 16.52% |
| 3 | Communication Services | 14.27% |
| 4 | Industrials | 10.24% |
| 5 | Consumer Discretionary | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Synaptics
SYNA
$4.19B
| – | – |
-10,584
| Closed | -$850K |
|
77
Teva Pharmaceuticals
TEVA
$40.8B
| – | – |
-2,500
| Closed | -$164K |
|
78
Williams Companies
WMB
$87.5B
| – | – |
-2,000
| Closed | -$56K |
|
|
SUM
79
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| – | – |
-626
| Closed | -$12K |
|
|
SGEN
80
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
-2,000
| Closed | -$90K |
|
|
TA
81
DELISTED
TravelCenters of America LLC
TA
| – | – |
-400
| Closed | -$50K |
|
|
PBCT
82
DELISTED
People's United Financial Inc
PBCT
| – | – |
-4,000
| Closed | -$65K |
|
|
ALDR
83
DELISTED
Alder Biopharmaceuticals
ALDR
| – | – |
-1,000
| Closed | -$33K |
|
|
WFT
84
DELISTED
Weatherford International plc
WFT
| – | – |
-3,000
| Closed | -$25K |
|
|
ANDV
85
DELISTED
Andeavor
ANDV
| – | – |
-1,000
| Closed | -$105K |
|
|
FNFG
86
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| – | – |
-4,000
| Closed | -$43K |
|
|
BXLT
87
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| – | – |
-1,000
| Closed | -$39K |
|
Similar funds
GC
GCS
NI
CMANY
GMC
JCM
PCA
ACM
Tanaka Capital Management's Q1 2016 Portfolio in Review
As of Q1 2016, Tanaka Capital Management held 93 positions worth $44.4M, down 4.3% from $46.4M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Tanaka Capital Management's Q1 2016 filing shows 3 new, 8 increased, 23 reduced and 34 closed positions. Its largest new stake was ProShares UltraPro Short S&P 500: 55 shares worth $641K. The largest sale was Bausch Health, an estimated $2.12M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Communication Services.
- Tanaka Capital Management's largest Q1 2016 buy was ProShares UltraPro Short S&P 500: 55 shares worth $641K.
- Tanaka Capital Management added most to Lions Gate Entertainment in Q1 2016, an estimated $1.85M increase.
- Tanaka Capital Management's biggest Q1 2016 reduction was Celgene Corp, cutting an estimated $713K.
- Tanaka Capital Management fully exited Bausch Health in Q1 2016, selling an estimated $2.12M.
- Tanaka Capital Management's ten largest holdings make up 62% of its $44.4M portfolio in Q1 2016.
- Tanaka Capital Management opened 3 new positions and closed 34 in Q1 2016.
- Tanaka Capital Management's portfolio value fell 4.3% quarter-over-quarter to $44.4M.
Based on Tanaka Capital Management's 13F filing for Q1 2016, filed 16 May 2016.